Pharmaceuticals firm Biological E on Monday announced that it has slashed down the price of its Covid 19 vaccine Corbevax. The price has now been cut down to Rs 250 from Rs 840 a dose. The new price is inclusive of GST, for private vaccination centers. The price cut would result in end users paying a price of Rs 400 a dose, including taxes and administration charges, the company said in a statement.
Previously, in private vaccination centres the overall cost to end users of the vaccine was Rs 990 a dose, including taxes and administration charges, it added.
In March this year when the inoculation of children in the age group of 12 to 14 years against COVID-19 commenced in the country, Corbevax vaccine was used and its price was fixed at Rs 145 for government vaccination programme.
"BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children against the virus," the company said.
In April this year India's drug regulator had granted Emergency Use Authorisation (EUA) for Biological E's Corbevax for children in 5 to 12 years group along with Bharat Biotech's Covaxin for children in the age group of 6 to 12 years.
(With PTI Inputs)
Latest India News
